These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8382801)

  • 41. Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody.
    Sugimoto Y; Tsukahara S; Oh-hara T; Isoe T; Tsuruo T
    Cancer Res; 1990 Nov; 50(21):6925-30. PubMed ID: 2170010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring the cellular activity of camptothecin-triple-helix-forming oligonucleotide conjugates.
    Arimondo PB; Thomas CJ; Oussedik K; Baldeyrou B; Mahieu C; Halby L; Guianvarc'h D; Lansiaux A; Hecht SM; Bailly C; Giovannangeli C
    Mol Cell Biol; 2006 Jan; 26(1):324-33. PubMed ID: 16354702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes.
    Meng LH; Zhang JS; Ding J
    Biochem Pharmacol; 2001 Sep; 62(6):733-41. PubMed ID: 11551518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequential modifications of topoisomerase I activity in a camptothecin-resistant cell line established by progressive adaptation.
    Madelaine I; Prost S; Naudin A; Riou G; Lavelle F; Riou JF
    Biochem Pharmacol; 1993 Jan; 45(2):339-48. PubMed ID: 8382060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53.
    Gobert C; Skladanowski A; Larsen AK
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10355-60. PubMed ID: 10468612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Real-time analysis of cleavage and religation activity of human topoisomerase 1 based on ternary fluorescence resonance energy transfer DNA substrate.
    Wang Z; Ouyang H; Tesauro C; Ottaviani A; He Y; Fiorani P; Xie H; Desideri A; Fu Z
    Arch Biochem Biophys; 2018 Apr; 643():1-6. PubMed ID: 29458004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations of vaccinia virus DNA topoisomerase I that stabilize the cleavage complex.
    Gupta M; Zhu CX; Tse-Dinh YC
    J Biol Chem; 1994 Jan; 269(1):573-8. PubMed ID: 8276853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin.
    Tanizawa A; Kohn KW; Pommier Y
    Nucleic Acids Res; 1993 Nov; 21(22):5157-66. PubMed ID: 8255771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase I.
    Arimondo PB; Boutorine A; Baldeyrou B; Bailly C; Kuwahara M; Hecht SM; Sun JS; Garestier T; Hélène C
    J Biol Chem; 2002 Feb; 277(5):3132-40. PubMed ID: 11724801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of topoisomerase I mutations affecting both DNA cleavage and interaction with camptothecin.
    Li XG; Haluska P; Hsiang YH; Bharti A; Kufe DW; Rubin EH
    Ann N Y Acad Sci; 1996 Dec; 803():111-27. PubMed ID: 8993505
    [No Abstract]   [Full Text] [Related]  

  • 51. Retroviral expression of a mutant (Gly-533) human DNA topoisomerase I cDNA confers a dominant form of camptothecin resistance.
    Yanase K; Sugimoto Y; Andoh T; Tsuruo T
    Int J Cancer; 1999 Mar; 81(1):134-40. PubMed ID: 10077164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I.
    Porter SE; Champoux JJ
    Nucleic Acids Res; 1989 Nov; 17(21):8521-32. PubMed ID: 2555774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oligonucleotide cleavage and rejoining by topoisomerase III from the hyperthermophilic archaeon Sulfolobus solfataricus: temperature dependence and strand annealing-promoted DNA religation.
    Chen L; Huang L
    Mol Microbiol; 2006 May; 60(3):783-94. PubMed ID: 16629677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.
    Eng WK; McCabe FL; Tan KB; Mattern MR; Hofmann GA; Woessner RD; Hertzberg RP; Johnson RK
    Mol Pharmacol; 1990 Oct; 38(4):471-80. PubMed ID: 2172765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccinia DNA topoisomerase I: single-turnover and steady-state kinetic analysis of the DNA strand cleavage and ligation reactions.
    Stivers JT; Shuman S; Mildvan AS
    Biochemistry; 1994 Jan; 33(1):327-39. PubMed ID: 8286354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of topoisomerase I catalytic activity as determinant of drug response in human cancer cell lines.
    Voigt W; Vanhoefer U; Yin MB; Minderman H; Schmoll HJ; Rustum YM
    Anticancer Res; 1997; 17(5A):3707-11. PubMed ID: 9413228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular mechanism of the camptothecin resistance of Glu710Gly topoisomerase IB mutant analyzed in vitro and in silico.
    Tesauro C; Morozzo della Rocca B; Ottaviani A; Coletta A; Zuccaro L; Arnò B; D'Annessa I; Fiorani P; Desideri A
    Mol Cancer; 2013 Sep; 12(1):100. PubMed ID: 24004603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Poly(ADP-ribose) polymerase-1 could facilitate the religation of topoisomerase I-linked DNA inhibited by camptothecin.
    Park SY; Cheng YC
    Cancer Res; 2005 May; 65(9):3894-902. PubMed ID: 15867389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sequence specificity of DNA topoisomerase I in the presence and absence of camptothecin.
    Thomsen B; Mollerup S; Bonven BJ; Frank R; Blöcker H; Nielsen OF; Westergaard O
    EMBO J; 1987 Jun; 6(6):1817-23. PubMed ID: 3038537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Substitution of conserved residues within the active site alters the cleavage religation equilibrium of DNA topoisomerase I.
    Colley WC; van der Merwe M; Vance JR; Burgin AB; Bjornsti MA
    J Biol Chem; 2004 Dec; 279(52):54069-78. PubMed ID: 15489506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.